South Africa has started the first human trials for a Covid-19 vaccine in Africa aimed at producing a potential vaccine against the novel coronavirus plaguing the world.
The trial vaccine will be tested on people between the ages of 18 and 65 including HIV positive patients. These volunteers will who receive the vaccination will be monitored for 12 months to see how well the vaccine guards against COVID-19.
Countries that have already taken part in this COVID-19 trial include the United Kingdom with 4,000 volunteers. Testing is also ongoing in Brazil.
However, skepticism surrounds the ongoing COVID-19 trial vaccine in Africa because of a history of big pharmaceutical companies using Africans as guinea pigs.
"I feel a little bit scared, but I want to know what is going on with this vaccine so that I can tell my friends and others," said Junior Mhlongo, a volunteer who received the vaccine at a hospital in Johannesburg.
Oxford University scientists, who developed the vaccine, also known as AZD1222, are working with AstraZeneca on development and production.
South Africa currently has the highest rate of COVID-19 infections in the African continent, with more than 100,000 cases and more than 2,000 deaths registered.
EURO 2020 match …
Arrested…
Almost l…
Recent Comments(0)